Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment?

Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment?

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive muscular atrophy and death within 3–5 years after its onset. Despite the significant advances in knowledge of ALS pathology, no effective treatment is available. Therefore, it is imperative to search for...

Full description

Bibliographic Details
Main Authors: Fernanda Gubert, Marcelo F Satiago
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Neural Regeneration Research
Subjects:
amyotrophic lateral sclerosis; cell therapy; bone-marrow mononuclear cells; mesenchymal stromal cells; neuroinflammation; motor neurons
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=8;spage=1216;epage=1219;aulast=Gubert

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=8;spage=1216;epage=1219;aulast=Gubert

Similar Items